Literature DB >> 15044387

Mobilization of neutrophil sialidase activity desialylates the pulmonary vascular endothelial surface and increases resting neutrophil adhesion to and migration across the endothelium.

Serhan Sakarya1, Salahaldin Rifat, Jie Zhou, Douglas D Bannerman, Nicholas M Stamatos, Alan S Cross, Simeon E Goldblum.   

Abstract

The amount of sialic acid on the surface of the neutrophil (PMN) influences its ability to interact with other cells. PMN activation with various stimuli mobilizes intracellular sialidase to the plasma membrane, where it cleaves sialic acid from cell surfaces. Because enhanced PMN adherence, spreading, deformability, and motility each are associated with surface desialylation and are critical to PMN diapedesis, we studied the role of sialic acid on PMN adhesion to and migration across pulmonary vascular endothelial cell (EC) monolayers in vitro. Neuraminidase treatment of either PMN or EC increased adhesion and migration in a dose-dependent manner. Neuraminidase treatment of both PMNs and ECs increased PMN adhesion to EC more than treatment of either PMNs or ECs alone. Moreover, neuraminidase treatment of ECs did not change surface expression of adhesion molecules or release of IL-8 and IL-6. Inhibition of endogenous sialidase by either cross-protective antineuraminidase antibodies (45.5% inhibition) or competitive inhibition with pseudo-substrate (41.2% inhibition) decreased PMN adhesion to ECs; the inhibitable sialidase activity appeared to be associated with activated PMNs. Finally, EC monolayers preincubated with activated PMNs became hyperadhesive for subsequently added resting PMNs, and this hyperadhesive state was mediated through endogenous PMN sialidase activity. Blocking anti-E-selectin, anti-CD54 and anti-CD18 antibodies decreased PMN adhesion to tumor necrosis factor-activated ECs but not to PMN-treated ECs. These data implicate desialylation as a novel mechanism through which PMN-EC adhesion can be regulated independent of de novo protein synthesis or altered adhesion molecule expression. The ability of activated PMNs, through endogenous sialidase activity, to render the EC surface hyperadherent for unstimulated PMNs may provide for rapid amplification of the PMN-mediated host response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044387     DOI: 10.1093/glycob/cwh065

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  29 in total

1.  NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.

Authors:  Alan S Cross; Sang Won Hyun; Alba Miranda-Ribera; Chiguang Feng; Anguo Liu; Chinh Nguyen; Lei Zhang; Irina G Luzina; Sergei P Atamas; William S Twaddell; Wei Guang; Erik P Lillehoj; Adam C Puché; Wei Huang; Lai-Xi Wang; Antonino Passaniti; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

2.  Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity.

Authors:  Donna L Cioffi; Subha Pandey; Diego F Alvarez; Eugene A Cioffi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

3.  LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity.

Authors:  Nicholas M Stamatos; Ivan Carubelli; Diantha van de Vlekkert; Erik J Bonten; Nadia Papini; Chiguang Feng; Bruno Venerando; Alessandra d'Azzo; Alan S Cross; Lai-Xi Wang; Peter J Gomatos
Journal:  J Leukoc Biol       Date:  2010-09-08       Impact factor: 4.962

4.  Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice.

Authors:  Elizabeth J White; Gabriel Gyulay; Šárka Lhoták; Magdalena M Szewczyk; Taryne Chong; Mark T Fuller; Omid Dadoo; Alison E Fox-Robichaud; Richard C Austin; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Biol Chem       Date:  2018-08-10       Impact factor: 5.157

5.  NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Irina G Luzina; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

6.  Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity.

Authors:  Nirav G Shah; Mohan E Tulapurkar; Aparna Ramarathnam; Amanda Brophy; Ramon Martinez; Kellie Hom; Theresa Hodges; Ramin Samadani; Ishwar S Singh; Alexander D MacKerell; Paul Shapiro; Jeffrey D Hasday
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

7.  Targeting of Neutrophil Lewis X Blocks Transepithelial Migration and Increases Phagocytosis and Degranulation.

Authors:  Jennifer C Brazil; Ronen Sumagin; Richard D Cummings; Nancy A Louis; Charles A Parkos
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

8.  NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.

Authors:  Chunsik Lee; Anguo Liu; Alba Miranda-Ribera; Sang Won Hyun; Erik P Lillehoj; Alan S Cross; Antonino Passaniti; P Richard Grimm; Bo-Young Kim; Paul A Welling; Joseph A Madri; Horace M DeLisser; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

9.  Expression of sialyltransferase activity on intact human neutrophils.

Authors:  Salahaldin Rifat; Tae Jin Kang; Dean Mann; Lei Zhang; Adam C Puche; Nicholas M Stamatos; Simeon E Goldblum; Reinhard Brossmer; Alan S Cross
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

10.  Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice.

Authors:  Abraham Yang; Gabriel Gyulay; Mark Mitchell; Elizabeth White; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Lipid Res       Date:  2012-09-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.